The Serum Institute of India (SII), the world's biggest vaccine maker, has nearly quadrupled its monthly capacity of AstraZeneca (AZN.L) shots to as many as 240 million doses and is prepared to export "large volumes" from January, its CEO told Reuters.
The restart will be a huge boost to poorer n
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
